Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies

Biochemical Pharmacology
Yun-Li YuGuang-Ji Wang

Abstract

Glucagon-like peptide (GLP)-1 is a potent glucose-dependent insulinotropic gut hormone released from intestinal L cells. Our previous studies showed that berberine increased GLP-1 secretion in streptozotocin-induced diabetic rats. The aim of this study was to investigate whether berberine affected GLP-1 release in normal rats and in NCI-H716 cells. Proglucagon and prohormone convertase 3 genes regulating GLP-1 biosynthesis were analyzed by RT-PCR. Effects of pharmacological inhibitors on berberine-mediated GLP-1 release were studied. In vivo, 5-week treatment of berberine enhanced GLP-1 secretion induced by glucose load and promoted proglucagon mRNA expression as well as L cell proliferation in intestine. In vitro, berberine concentration-dependently stimulated GLP-1 release in NCI-H716 cells. Berberine also promoted both prohormone convertase 3 and proglucagon mRNA expression. Chelerythrine (inhibitor of PKC) concentration-dependently suppressed berberine-mediated GLP-1 secretion. Compound C (inhibitor of AMPK) also inhibited berberine-mediated GLP-1 secretion. But only low concentrations of H89 (inhibitor of PKA) showed inhibitory effects on berberine-mediated GLP-1 release. The present results demonstrated that berberine sho...Continue Reading

References

Jan 1, 1992·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·A P de BruïneF T Bosman
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·S P Cole
Jan 24, 2003·Diabetes·Younes Anini, Patricia L Brubaker
Jun 18, 2003·Endocrinology·Younes Anini, Patricia L Brubaker
Aug 5, 2005·Biological & Pharmaceutical Bulletin·Byoung-Seob KoSunmin Park
Oct 13, 2006·Journal of Agricultural and Food Chemistry·Aukje SteensmaIvonne M C M Rietjens
Oct 20, 2006·Biochimica Et Biophysica Acta·Zhe ChengJia Li
Jan 12, 2007·Cardiovascular Drug Reviews·A Lochner, J A Moolman
Oct 12, 2007·Physiological Reviews·Jens Juul Holst
Apr 30, 2008·Metabolism: Clinical and Experimental·Jun YinJianping Ye
Dec 9, 2008·Metabolism: Clinical and Experimental·Wei-Jia KongJian-Dong Jiang
Jun 6, 2009·Journal of Ethnopharmacology·Yun-Li YuXiao-Dong Liu

❮ Previous
Next ❯

Citations

May 4, 2013·Metabolic Brain Disease·Hamid Kalalian MoghaddamAbdolaziz Ronaghi
Jun 24, 2011·Journal of Agricultural and Food Chemistry·Wei-Han Chueh, Jin-Yuarn Lin
Aug 30, 2012·The American Journal of Chinese Medicine·Xiao-Lin TongZhong Zhen
Jun 29, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Junling HanWeiping Huang
Feb 9, 2011·Gastroenterology·Mehdi DaoudiSophie Lestavel
Mar 15, 2011·Drug Metabolism Reviews·Fang ZhouMichael S Roberts
Jul 31, 2012·Medical Hypotheses·A B RahigudeP S Bhutada
Oct 7, 2010·Journal of Diabetes·Xuan Xia, Jianping Weng
Dec 6, 2012·TheScientificWorldJournal·Xiao-Wu ChenShu-Feng Zhou
May 18, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Weidong XieYaou Zhang
Jul 25, 2015·Biochemical Pharmacology·Yunli YuXiaozhou Wen
Dec 1, 2012·Current Therapeutic Research, Clinical and Experimental·Quan YiJian-Dong Luo
Oct 30, 2016·Critical Reviews in Food Science and Nutrition·Montserrat PinentAnna Ardévol
Apr 11, 2015·International Journal of Endocrinology·Bing PangXiao-Lin Tong
Jan 22, 2015·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Wenguang ChangGrant M Hatch
Jan 25, 2018·Molecular and Cellular Biochemistry·Xiao YueFuxue Chen
Sep 15, 2017·Critical Reviews in Food Science and Nutrition·Luigi BarreaSilvia Savastano
Dec 29, 2013·American Journal of Physiology. Cell Physiology·Noemi González-AbuínAnna Ardévol
Aug 5, 2014·Food & Function·Noemi González-AbuínMontserrat Pinent
Dec 8, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Nan HuGuangji Wang
May 2, 2018·Current Medicinal Chemistry·Maria-Ioanna ChristodoulouMaria Halabalaki
Feb 28, 2016·Chinese Journal of Integrative Medicine·Hao-Ying DouHong-Wu Wang
Apr 15, 2015·Current Opinion in Supportive and Palliative Care·Hannelouise Kissow
Oct 23, 2016·Journal of Biomedical Science·Cheng-Fu ChangChi-Chen Huang
Jun 23, 2018·Chinese Medicine·Jin WangQin-Wan Huang
Feb 7, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Wenfeng DuanBaoxiang Gao
Nov 14, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xinmei XuGang Fan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.